Sumit Aggarwal is PRESIDENT AND CEO of Eloxx Pharmaceuticals, Inc.. Currently has a direct ownership of 169,930 shares of ELOX, which is worth approximately $0. The most recent transaction as insider was on Oct 16, 2024, when has been sold 165,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 170K
13.84% 3M change
13.84% 12M change
Total Value Held $0

Sumit Aggarwal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 16 2024
BUY
Grant, award, or other acquisition
-
165,000 Added 49.26%
169,930 Common Stock
Dec 01 2021
SELL
Payment of exercise price or tax liability
$58,992 $0.72 p/Share
81,933 Reduced 29.35%
197,225 Common Stock
Dec 01 2021
BUY
Exercise of conversion of derivative security
-
279,158 Added 50.0%
279,158 Common Stock
SA

Sumit Aggarwal

PRESIDENT AND CEO
Waltham, MA

Track Institutional and Insider Activities on ELOX

Follow Eloxx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELOX shares.

Notify only if

Insider Trading

Get notified when an Eloxx Pharmaceuticals, Inc. insider buys or sells ELOX shares.

Notify only if

News

Receive news related to Eloxx Pharmaceuticals, Inc.

Track Activities on ELOX